Prescription opioid use in advanced COPD: benefits, perils and controversies Source: Eur Respir J, 49 (6) 1700690; 10.1183/13993003.00690-2017 Year: 2017
Prescription opioid use in advanced COPD: benefits, perils and controversies Source: Eur Respir J, 49 (6) 1700479; 10.1183/13993003.00479-2017 Year: 2017
Getting approval for new therapeutic medical devices versus drugs: are the differences justified? Source: Eur Respir Rev 2016; 25: 223-226 Year: 2016
The sustainability agenda and inhaled therapy: what do patients want? Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence Year: 2021
Preventing skin care issues associated with face masks used for domiciliary non-invasive ventilation: what do users and their carers think are the most relevant future research questions? Source: International Congress 2019 – Treatment of chronic respiratory failure with noninvasive ventilation Year: 2019
What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018 Year: 2018
Who can pay for innovative medicines? Source: Eur Respir J 2013; 41: 495-496 Year: 2013
The paradoxes of asthma management: time for a new approach? Source: Eur Respir J, 50 (3) 1701103; 10.1183/13993003.01103-2017 Year: 2017
What are the key issues in the inhaler therapy in children? Source: Annual Congress 2004 - How can we improve asthma management? Year: 2004
Acceptance criteria for intensive care: we need new definitions and legislations for futile treatment! Source: International Congress 2017 – COPD and weaning Year: 2017
Rational monitoring of COPD: where do current clinical guidelines stand? Source: Eur Respir J 2007; 29: 1078-1081 Year: 2007
Do we really need guidelines? Source: Virtual Congress 2020 – Do we really need guidelines? Year: 2020
Do general practitioners use effective communication for discussing patients‘ adherence with asthma medications? Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care Year: 2012
Spacer devices for inhaled therapy: why use them, and how? Source: ERJ Open Res, 4 (2) 00065-2018; 10.1183/23120541.00065-2018 Year: 2018
Update on novel anticoagulants: indications, dosing alternatives and outcomes Source: International Congress 2018 – Pulmonary embolism: what we need to know Year: 2018
Do technologies make a difference in adherence to treatment: instant messaging application use? Source: Virtual Congress 2020 – Digital health interventions in respiratory medicine Year: 2020
Respiratory medicines for children: current evidence, unlicensed use and research priorities Source: Eur Respir J 2010; 35: 247-265 Year: 2010
“I don’t think there’s a simple way of doing it:” the use of an electronic alert to identify excessive prescribing of short-acting beta2-agonists for people with asthma – a qualitative study with asthma experts and primary care staff Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care Year: 2020